We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Gates Industrial Corp
GTES
$6.54B
| $2.96M | 0.01% |
128,520
+18,208
| +17% | +$367K |
2024 Q3
3 quarters
|
|
852
Marsh
MRSH
$89.9B
| $2.96M | 0.01% |
13,518
-2,597
| -16% | -$586K |
2013 Q2
48 quarters
|
|
853
Alpha Metallurgical Resources
AMR
$2.11B
| $2.92M | 0.01% |
25,931
+294
| +1% | +$34.4K |
2024 Q2
4 quarters
|
|
854
Cerence
CRNC
$404M
| $2.92M | 0.01% |
285,519
+39,318
| +16% | +$346K |
2019 Q4
22 quarters
|
|
855
Federated Hermes MDT Large Cap Core ETF
FLCC
$174M
| $2.88M | 0.01% |
95,004
| – | – |
2024 Q3
3 quarters
|
|
856
Burford Capital
BUR
$659M
| $2.85M | 0.01% |
199,913
-195,322
| -49% | -$2.55M |
2020 Q4
18 quarters
|
|
857
Avnet
AVT
$7.4B
| $2.83M | 0.01% |
53,313
-12,406
| -19% | -$616K |
2013 Q2
48 quarters
|
|
858
Ingredion
INGR
$6.18B
| $2.8M | 0.01% |
20,657
-4,172
| -17% | -$563K |
2013 Q2
48 quarters
|
|
859
Polaris
PII
$2.97B
| $2.8M | 0.01% |
68,871
+66,976
| +3,534% | +$2.52M |
2013 Q2
48 quarters
|
|
860
Federated Hermes MDT Large Cap Value ETF
FLCV
$175M
| $2.8M | 0.01% |
95,004
| – | – |
2024 Q3
3 quarters
|
|
861
CACI
CACI
$13.6B
| $2.77M | 0.01% |
5,821
-70
| -1% | -$31K |
2013 Q2
48 quarters
|
|
862
Casella Waste Systems
CWST
$5.6B
| $2.77M | 0.01% |
+23,994
| New | +$2.77M |
2025 Q2
0 quarters
|
|
863
Phillips 66
PSX
$117B
| $2.77M | 0.01% |
23,193
-4,348
| -16% | -$487K |
2013 Q2
48 quarters
|
|
864
Herc Holdings
HRI
$4.06B
| $2.75M | 0.01% |
20,918
+20,751
| +12,426% | +$2.52M |
2024 Q1
5 quarters
|
|
865
DELISTED
Verint Systems
VRNT
| $2.73M | 0.01% |
138,972
+126,342
| +1,000% | +$2.21M |
2021 Q3
15 quarters
|
|
866
Ardmore Shipping
ASC
$773M
| $2.69M | 0.01% |
280,418
+5,356
| +2% | +$51.6K |
2022 Q3
11 quarters
|
|
867
East-West Bancorp
EWBC
$17.4B
| $2.68M | 0.01% |
26,559
-3,303
| -11% | -$293K |
2013 Q2
48 quarters
|
|
868
BioCryst Pharmaceuticals
BCRX
$1.99B
| $2.67M | 0.01% |
298,201
+113,297
| +61% | +$1.06M |
2024 Q3
3 quarters
|
|
869
Teladoc Health
TDOC
$1.03B
| $2.67M | 0.01% |
306,250
-92,541
| -23% | -$671K |
2018 Q3
27 quarters
|
|
870
Manitowoc
MTW
$777M
| $2.65M | 0.01% |
220,837
-445
| -0.2% | -$4.37K |
2022 Q2
12 quarters
|
|
871
Preferred Bank
PFBC
$1.24B
| $2.64M | 0.01% |
30,509
-102
| -0.3% | -$8.41K |
2013 Q3
47 quarters
|
|
872
Academy Sports + Outdoors
ASO
$3.61B
| $2.64M | 0.01% |
58,921
+3,255
| +6% | +$135K |
2020 Q4
18 quarters
|
|
873
Hancock Whitney
HWC
$5.86B
| $2.63M | ﹤0.01% |
45,798
-2,495
| -5% | -$133K |
2013 Q2
48 quarters
|
|
874
OceanFirst Financial
OCFC
$1.53B
| $2.61M | ﹤0.01% |
148,319
-5,482
| -4% | -$91.4K |
2023 Q4
6 quarters
|
|
875
Federated Hermes MDT Small Cap Core ETF
FSCC
$415M
| $2.6M | ﹤0.01% |
100,004
| – | – |
2024 Q3
3 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.